Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norepinephrine reuptake is the process by which norepinephrine (noradrenaline) is removed from the synaptic cleft and transported back into the presynaptic neuron via the norepinephrine transporter (NET). This mechanism regulates norepinephrine levels in synapses, controlling its duration and intensity of action on postsynaptic adrenergic receptors. Inhibition of norepinephrine reuptake increases noradrenergic signaling and is a target for drugs used in treating major depressive disorder, anxiety disorders, ADHD, narcolepsy, and chronic pain.
Blockade of the norepinephrine transporter (NET), leading to increased extracellular norepinephrine concentrations and enhanced adrenergic neurotransmission.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine Reuptake (None).